These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. Al-Shaer MH; Alghamdi WA; Alsultan A; An G; Ahmed S; Alkabab Y; Banu S; Barbakadze K; Houpt E; Kipiani M; Mikiashvili L; Cegielski JP; Kempker RR; Heysell SK; Peloquin CA Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061152 [TBL] [Abstract][Full Text] [Related]
16. Corticosteroids for tuberculous pleurisy. Ryan H; Yoo J; Darsini P Cochrane Database Syst Rev; 2017 Mar; 3(3):CD001876. PubMed ID: 28290161 [TBL] [Abstract][Full Text] [Related]
17. Rifamycins (rifampicin, rifabutin and rifapentine) compared to isoniazid for preventing tuberculosis in HIV-negative people at risk of active TB. Sharma SK; Sharma A; Kadhiravan T; Tharyan P Evid Based Child Health; 2014 Mar; 9(1):169-294. PubMed ID: 25404581 [TBL] [Abstract][Full Text] [Related]
18. Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis. ; Ahmad N; Ahuja SD; Akkerman OW; Alffenaar JC; Anderson LF; Baghaei P; Bang D; Barry PM; Bastos ML; Behera D; Benedetti A; Bisson GP; Boeree MJ; Bonnet M; Brode SK; Brust JCM; Cai Y; Caumes E; Cegielski JP; Centis R; Chan PC; Chan ED; Chang KC; Charles M; Cirule A; Dalcolmo MP; D'Ambrosio L; de Vries G; Dheda K; Esmail A; Flood J; Fox GJ; Fréchet-Jachym M; Fregona G; Gayoso R; Gegia M; Gler MT; Gu S; Guglielmetti L; Holtz TH; Hughes J; Isaakidis P; Jarlsberg L; Kempker RR; Keshavjee S; Khan FA; Kipiani M; Koenig SP; Koh WJ; Kritski A; Kuksa L; Kvasnovsky CL; Kwak N; Lan Z; Lange C; Laniado-Laborín R; Lee M; Leimane V; Leung CC; Leung EC; Li PZ; Lowenthal P; Maciel EL; Marks SM; Mase S; Mbuagbaw L; Migliori GB; Milanov V; Miller AC; Mitnick CD; Modongo C; Mohr E; Monedero I; Nahid P; Ndjeka N; O'Donnell MR; Padayatchi N; Palmero D; Pape JW; Podewils LJ; Reynolds I; Riekstina V; Robert J; Rodriguez M; Seaworth B; Seung KJ; Schnippel K; Shim TS; Singla R; Smith SE; Sotgiu G; Sukhbaatar G; Tabarsi P; Tiberi S; Trajman A; Trieu L; Udwadia ZF; van der Werf TS; Veziris N; Viiklepp P; Vilbrun SC; Walsh K; Westenhouse J; Yew WW; Yim JJ; Zetola NM; Zignol M; Menzies D Lancet; 2018 Sep; 392(10150):821-834. PubMed ID: 30215381 [TBL] [Abstract][Full Text] [Related]
19. Effects of Fluroquinolones in Newly Diagnosed, Sputum-Positive Tuberculosis Therapy: A Systematic Review and Network Meta-Analysis. Li D; Wang T; Shen S; Cheng S; Yu J; Zhang Y; Zhang C; Tang H PLoS One; 2015; 10(12):e0145066. PubMed ID: 26669635 [TBL] [Abstract][Full Text] [Related]
20. Fluoroquinolones for the treatment of tuberculosis in children. Thee S; Garcia-Prats AJ; Donald PR; Hesseling AC; Schaaf HS Tuberculosis (Edinb); 2015 May; 95(3):229-45. PubMed ID: 25797610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]